Your Article Summary
See Latest ArticlesAstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09
Two studies from AstraZeneca show that symptomatic gastroesophageal reflux disease patients treated with NEXIUM 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks.1 NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated with GERD. NEXIUM, in a class of drugs called proton pump inhibitors, demonstrated efficacy in relieving moderate-to-severe nighttime heartburn and GERD-related sleep disturbances in two randomized, placebo-controlled trials.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/09/09
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/09/09
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Trials, 12/09/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
Clinical Pharmacology & Therapeutics, 12/08/09
Amgen Presents Data From First Nplate Study in Children With Chronic ITP
Amgen, 12/08/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
Gastroenterology, 12/09/09
New insights into the regulation of cytochrome P450 2C9 gene expression: the role of the transcription factor GATA-4
Drug Metabolism and Disposition, 12/09/09
Monocarboxylate Transporter (MCT)-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells
Drug Metabolism and Disposition, 12/08/09